Best-Performing Pot Stocks Following 4/20 2018
In 2018, 4/20 marked the beginning of a blazing run for a number of cannabis companies.
In 2018, 4/20 marked the beginning of a blazing run for a number of cannabis companies.
Canopy Growth has secured the right to snatch up the largest MSO in the U.S. for a whopping $3.4 billion.
As each 4/20 comes and goes, the outlook for the cannabis sector gets brighter – not hazier. This year is one to celebrate.
Even though there’s been a steep pullback in shares, is the cannabis sector still overvalued?
Cannabis companies are spending a lot for growth, so profits are hard to come by. But these 10 pot stocks are making them.
Martha Stewart signed on as an advisor for Canopy Growth to create a line of CBD products for animals.
Matthew shares which stocks are overpriced and which are ripe for the taking.
There are roughly 200 publicly traded cannabis companies… and many of them reported earnings last week.
The majority of U.S. states have given the thumbs-up to medical cannabis. The federal government won’t be far behind.
The S&P 500 is now negative for the year. And shares of cannabis companies have been in free fall since October 16.